Local anesthetic and steroidal prostatic injection for chronic pelvic pain syndrome: An effective last resort?

Clinical Journal of Pain

Volumn 27, Issue 2, 2011, Pages 166-168

  Koo, Vincent S W ^a   Obrien, Aidan ^a  

^a CRAIGAVON AREA HOSPITAL   (United Kingdom)

Author keywords

chronic pelvic pain syndrome; chronic prostatitis; local anesthesia; prostatic injection

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIBIOTIC AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; KETAMINE; LEVOBUPIVACAINE; METHYLPREDNISOLONE ACETATE; MUSCLE RELAXANT AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PENTOSAN POLYSULFATE; STEROID; STEROID 5ALPHA REDUCTASE INHIBITOR;

ADULT; ARTICLE; BLADDER NECK STENOSIS; CASE REPORT; CHRONIC PROSTATITIS; GENERAL ANESTHESIA; HUMAN; LOCAL ANESTHESIA; MALE; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; SCROTAL PAIN; TRANSURETHRAL RESECTION;

EID: 79551567008     PISSN: 07498047     EISSN: 15365409     Source Type: Journal    
DOI: 10.1097/AJP.0b013e3181f89971     Document Type: Article

References (11)

1. Nickel JC, Downey J, Hunter D, et al. Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health Chronic Prostatitis Symptom Index. J Urol. 2001;165:842-845.
2. Krieger JN, Riley DE, Cheah PY, et al. Epidemiology of prostatitis: new evidence for a world-wide problem. World J Urol. 2003;21:70-74.
3. Nickel JC. Clinical evaluation of the man with chronic prostatitis/ chronic pelvic pain syndrome. Urology. 2002;60:20-22.
4. Litwin MS, McNaughton-Collins M, Fowler FJ Jr, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369-375.
5. Mayersak JS. Transrectal ultrasonography directed intraprostatic injection of gentamycin-xylocaine in the management of the benign painful prostate syndrome. A report of a 5 year clinical study of 75 patients. Int Surg. 1998;83:347-349.
6. Cho YH, Lee SJ, Lee JY, et al. Antibacterial effect of intraprostatic zinc injection in a rat model of chronic bacterial prostatitis. Int J Antimicrob Agents. 2000;19:576-582.
7. Chuang YC, Yoshimura N, Huang CC, et al. Intraprostatic botulinum toxin a injection inhibits cyclooxygenase-2 expression and suppresses prostatic pain on capsaicin induced prostatitis model in rat. J Urol. 2008;180:742-748.
8. Pontari MA, Ruggieri MR. Mechanisms in prostatitis/chronic pelvic pain syndrome. J Urol. 2004;172:839-845.
9. Orhan I, Onur R, Ilhan N, et al. Seminal plasma cytokine levels in the diagnosis of chronic pelvic pain syndrome. Int J Urol. 2001;8:495-499.
10. John H, Barghorn A, Funke G, et al. Noninflammatory chronic pelvic pain syndrome: immunological study in blood, ejaculate and prostate tissue. Eur Urol. 2001;39:72-78.
11. Vlaskovska M, Hertting G, Knepel W. Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotrophin-releasing factor. Endocrinology. 1984;115:895-903.